CPH
Click for more information
0.00% 0.9¢ creso pharma limited

Ann: Halucenex Phase II Clinical Trial Update, page-39

  1. changle
    1,045 Posts.
    lightbulb Created with Sketch. 52
    clock Created with Sketch.
    10/05/23
    12:21
    Post #: 67698523
    2c gone, 4c next target
    CPH Price at posting: 2.1¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

VMS Venture hits 1,839 TREO at Jupiter in WA with best intersection to date
right-arrow Created with Sketch.
NEWS Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market
right-arrow Created with Sketch.
DY6 DY6 Metals (ASX:DY6) shares soar as company flags historical rare earth hits
right-arrow Created with Sketch.
NEWS The Telstra twist - What the job cuts decision mean for investors?
right-arrow Created with Sketch.
TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans
right-arrow Created with Sketch.
ETM This ASX stock could sue Greenland's government for 4x its annual GDP
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.